Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation

被引：0
|
作者：
O Benjamini
M Koren-Michowitz
N Amariglio
N Kroger
A Nagler
A Shimoni
机构：
[1] Chaim Sheba Medical Center,Division of Hematology and Bone Marrow Transplantation
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1961 / 1963
页数：2
相关论文
共 50 条
  • [1] Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation
    Benjamini, O.
    Koren-Michowitz, M.
    Amariglio, N.
    Kroger, N.
    Nagler, A.
    Shimoni, A.
    LEUKEMIA, 2008, 22 (10) : 1961 - 1963
  • [2] JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation
    Kroeger, Nicolaus
    Alchalby, Haefaa
    Klyuchnikov, Evgeny
    Badbaran, Anita
    Hildebrandt, York
    Ayuk, Francis
    Bacher, Ulrike
    Bock, Oliver
    Kvasnicka, Michael
    Fehse, Boris
    Zander, Axel
    BLOOD, 2009, 113 (08) : 1866 - 1868
  • [3] Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis
    Kroeger, Nicolaus
    Badbaran, Anita
    Holler, Ernst
    Hahn, Joachim
    Kobbe, Guido
    Bornhaeuser, Martin
    Reiter, Andreas
    Zabelina, Tatjana
    Zander, Axel R.
    Fehse, Boris
    BLOOD, 2007, 109 (03) : 1316 - 1321
  • [4] Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation
    Helg, C
    Starobinski, M
    Jeannet, M
    Chapuis, B
    LEUKEMIA & LYMPHOMA, 1998, 29 (3-4) : 301 - 313
  • [5] No influence of V617F mutation in JAK2 on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis
    Ditschkowski, Markus
    Elmaagacli, Ahmet H.
    Trenschel, Rudolf
    Steckel, Nina K.
    Koldehoff, Michael
    Beelen, Dietrich W.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (12) : 1350 - 1351
  • [6] Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis
    Alchalby, Haefaa
    Badbaran, Anita
    Zabelina, Tatjana
    Kobbe, Guido
    Hahn, Joachim
    Wolff, Daniel
    Bornhaeuser, Martin
    Thiede, Christian
    Baurmann, Herrad
    Bethge, Wolfgang
    Hildebrandt, York
    Bacher, Ulrike
    Fehse, Boris
    Zander, Axel R.
    Kroeger, Nicolaus
    BLOOD, 2010, 116 (18) : 3572 - 3581
  • [7] Impact on survival of JAK2V617F-mutation status, allele burden and clearance after allogeneic stem cell transplantation for myelofibrosis
    Alchalby, H.
    Badbaran, A.
    Zabelina, T.
    Kobbe, G.
    Hahn, J.
    Bornhaeuser, M.
    Baurmann, H.
    Hildebrandt, Y.
    Bacher, U.
    Fehse, B.
    Zander, A. R.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S41 - S41
  • [8] JAK2-V617F-triggered pre-emptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis following allogeneic stem cell transplantation
    Alchalby, H.
    Klyuchnikov, E.
    Badbaran, A.
    Hildebrandt, Y.
    Ayuk, F.
    Bacher, U.
    Bock, O.
    Kvasnicka, M.
    Fehse, B.
    Zander, A.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S187 - S187
  • [9] Highly sensitive real-time PCR of V617F-JAK2-mutation to monitor minimal residual disease and guide donor lymphocte infusion after allogeneic stem cell transplantation in patients with myelofibrosis.
    Kroeger, Nicolaus
    Badbaran, Anita
    Holler, Ernst
    Hahn, Joachim
    Kobbe, Guido
    Bornhauser, Martin
    Reiter, Andreas
    Zabelina, Tatjana
    Zander, Axel
    Fehse, Boris
    BLOOD, 2006, 108 (11) : 201A - 201A
  • [10] Sensitive Molecular Detection of JAK2 V617F Is a Predictive Marker of Relapse in Patients with Myelofibrosis after Allogeneic Stem Cell Transplantation
    Nedumannil, Rithin
    Karmi, Tal
    Blombery, Piers
    Hughes, Charlotte
    Szer, Jeff
    Ritchie, David S.
    Chee, Lynette C. Y.
    BLOOD, 2023, 142
12345